Author's replyBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1501c (Published 02 December 1995) Cite this as: BMJ 1995;311:1501
- Morris J Brown, Professor
- Clinical Pharmacology Unit,University of Cambridge Clinical School, Addenbrooke's Hospital, Cambridge CB2 2QQ
EDITOR,--Ton J M Cleophas and Robert B Kalmansohn's letter is misleading. There is a twofold difference between the undisputed and sometimes fatal risk of asthma in patients taking a β blocker and the risks (if any) of the transiently higher blood pressure observed by the authors in a few patients admitted to hospital or undergoing …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial